Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2012
11/29/2012WO2012106670A8 Expandable liquid volume in an led bulb
11/29/2012WO2012050876A3 Nanowires for electrophysiological applications
11/29/2012US20120304340 Sclerotinia-resistant brassica
11/29/2012US20120304339 Sclerotinia-resistant brassica
11/29/2012US20120304338 Sclerotinia-resistant brassica
11/29/2012US20120304336 Chloroplast transit peptides and methods of their use
11/29/2012US20120304335 Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use
11/29/2012US20120304334 Argyranthemum Intergeneric Hybrid Plants and Methods of Production
11/29/2012US20120304333 Cotton Variety FM 2484B2F
11/29/2012US20120304332 Plants and seeds of hybrid corn variety ch041754
11/29/2012US20120304331 Herbicide tolerant soybean plants and methods for identifying same
11/29/2012US20120304330 Elite event ee-gm3 and methods and kits for identifying such event in biological samples
11/29/2012US20120304329 Cotton variety 11r159b2r2
11/29/2012US20120304328 Cotton variety 10r047b2r2
11/29/2012US20120304327 Cotton variety 10r008b2r2
11/29/2012US20120304326 Cotton variety 10r015b2r2
11/29/2012US20120304325 Cotton variety 10r051b2r2
11/29/2012US20120304324 Cotton variety 10r013b2r2
11/29/2012US20120304322 Method for acquiring genetically identical gamete from lethal fish haploid-derived germ cell via germ line chimera
11/29/2012US20120304321 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/29/2012US20120304319 Tox3 as a biomarker for breast cancer
11/29/2012US20120304317 Transgenic rodent expressing truncated disc1
11/29/2012US20120302815 Multi-valent poly-ubl chain inhibitors and methods of use
11/29/2012US20120302754 Production of alkaloids by liliaceae cell culture
11/29/2012US20120302738 Recombinant antibody vector
11/29/2012US20120302729 Anticancer anti-mortalin peptide antibody
11/29/2012US20120302649 Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
11/29/2012US20120302630 Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof
11/29/2012US20120302628 Oligonucleotides which inhibit p53 induction in response to cellular stress
11/29/2012US20120302625 Supercoiled minicircle dna for gene therapy applications
11/29/2012US20120302585 Inhibitors of fatty acid uptake and methods of use
11/29/2012US20120302578 Aminooxazole Inhibitors of Cyclin Dependent Kinases
11/29/2012US20120302575 Methods for Preventing Oxidative Stress Injury of a Tissue by a Folate-Tempol Conjugate.
11/29/2012US20120302514 Glycoconjugates and methods
11/29/2012US20120302511 Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer
11/29/2012US20120302506 Maspin-based treatment and prevention of cancer
11/29/2012US20120302492 Antibody Mimetic Scaffolds
11/29/2012US20120302466 T cell receptor-deficient t cell compositions
11/29/2012US20120302464 Methods for producing recombinant proteins
11/29/2012US20120302460 Use of Low Affinity Neurotrophin Receptor P75 As Marker for High Differentiation Potential Muscle Stem Cells, Muscle Satellite Cells, And Degenerative Skeletal Muscle Diseases
11/29/2012US20120301965 Cell programming
11/29/2012US20120301963 Covered micro gel fiber
11/29/2012US20120301962 Vitronectin-derived cell culture substrate and uses thereof
11/29/2012US20120301961 Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell
11/29/2012US20120301960 Lance Device and Associated Methods for Delivering a Biological Material Into a Cell
11/29/2012US20120301959 Cryoconserved Mature Dendritic Cells
11/29/2012US20120301958 Bioartificial proximal tubule systems and methods of use
11/29/2012US20120301957 Method and Apparatus for Collecting Biological Materials
11/29/2012US20120301956 Novel hydroxylated enantiomers of (-) 3a,6,6,9a-tetramethylperhydronaphtho[2,1-b]furan as perfuming agents derived from a fungal fermentation process
11/29/2012US20120301947 Enzymatic systems for carbon fixation and methods of generating same
11/29/2012US20120301945 Protease screening methods and proteases identified thereby
11/29/2012US20120301923 Dialysis fermenter-bioreactor with dialysis device
11/29/2012US20120301921 Compositions and methods of treating disease with fgfr fusion proteins
11/29/2012US20120301919 Ires mediated multicistronic vectors
11/29/2012US20120301899 Use of novel markers of pluripotent stem cells
11/29/2012US20120301883 Sheath flow devices and methods
11/29/2012US20120301873 Human long pentraxin 3 expression system and uses thereof
11/29/2012US20120301869 Particle separation devices, methods and systems
11/29/2012US20120301868 Extender for a semen suspension
11/29/2012US20120301867 Recovering nucleated red blood cells and method for concentrating and recovering nucleated red blood cells
11/29/2012US20120301866 Liquid formulation having dissolved gases useful for preserving biological material
11/29/2012US20120301507 Method of tissue repair
11/29/2012US20120301497 Plasmodium vivax Hybrid Circumsporozoite Protein and Vaccine
11/29/2012US20120301496 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/29/2012US20120301493 Applications of the protein muns and the derivates thereof
11/29/2012US20120301485 Juvenile Hemochromatosis Gene (HFE2A) Cleavage Products and Uses Thereof
11/29/2012US20120301483 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c
11/29/2012US20120301475 Novel heparanase splice variant
11/29/2012US20120301469 amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
11/29/2012US20120301467 Fas binding antibodies
11/29/2012US20120301465 Compositions and methods to immunize against hepatitis c virus
11/29/2012US20120301463 Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
11/29/2012US20120301462 Compounds
11/29/2012US20120301461 1d05 pcsk9 antagonists
11/29/2012US20120301453 Inhibiting integrin receptor binding with non-native monomeric disintegrin or monomeric disintegrin domains
11/29/2012US20120301449 Rna interference target for treating aids
11/29/2012US20120301447 TRUNCATED EPIDERIMAL GROWTH FACTOR RECEPTOR (EGFRt) FOR TRANSDUCED T CELL SELECTION
11/29/2012US20120301446 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders
11/29/2012US20120301445 Tools for isolating and following cardiovascular progenitor cells
11/29/2012US20120301443 Methods for developing endothelial cells from pluripotent cells and endothelial cells derived
11/29/2012US20120301440 Methods and materials for increasing potency of cells
11/29/2012US20120301438 Reprogramming Blood Cells to Pluripotent and Multipotent Stem Cells
11/29/2012US20120301429 Dac hyp compositions and methods
11/29/2012US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2012US20120301411 Modulating epigenetic dna methylation to cause cells to adopt dna methylation patterns associated with young cells
11/29/2012US20120301400 Meditopes and meditope-binding antibodies and uses thereof
11/29/2012US20120301395 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
11/29/2012DE102012003700B3 Verfahren zur Trennung von Verbänden maligner Zellen und Verbänden aus Stromazellen einer Malignomgewebeprobe Process for the separation of associations of malignant cells and stromal associations from a Malignomgewebeprobe
11/29/2012CA2837322A1 Cell and gene based methods to improve cardiac function
11/29/2012CA2836815A1 Plants having enhanced abiotic stress resistance
11/29/2012CA2836483A1 Neuronal progenitor cells and uses
11/29/2012CA2835222A1 Transgenic chicken comprising an inactivated immunoglobulin gene
11/29/2012CA2834584A1 Fgfr-fc fusion protein and use thereof
11/29/2012CA2831161A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
11/28/2012EP2527456A1 Transgenic porcines lacking endogenous immunoglobulin light chain
11/28/2012EP2527439A2 Compositions and methods related to mRNA translational enhancer elements
11/28/2012EP2527437A1 Novel anti-CD98 antibody
11/28/2012EP2527436A1 Nadh oxidase mutant having improved stability and use thereof
11/28/2012EP2527435A2 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT 8) gene expression
11/28/2012EP2527434A1 Probe reagent for measurement of protein decomposition activity
1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 1827